|
Oncovista or OVIT (CEO's last company was bought for $1 Billion)
0 Comment(s)
- Post a Comment
ONCOVISTA INNOVATIVE (OTC BB: OVIT) - Open
| Symbol | Position | Allocation | Picked | Current Price | |
|---|---|---|---|---|---|
| OVIT | Long | 10% | $0.3500 | $0.2200 | -37.14% |
| Opened | December 12, 2011 8:34:58 AM PST |
|---|---|
| Closed | - |
| Risk | High |
| Target Date | March 20, 2012 |
| Target Price | $1.0000 |
| Timeframe | Long-Term |
| Suggested Stop Loss | - |
| Holding | Long Position |
| Disclosure | - |
CEO's last company Genzyme bought for $1 Billion.
2 Drugs in the works, 1 for Leukemia and the other for Solid Tumors
Co-Founder of Ilex Oncology - the company Genzyme bought for $1 Billion.
YouTube Video: http://www.youtube.com/watch?v=Mh_RZMh-xcU
Insider Buying: http://finance.yahoo.com/q/it?s=OVIT.OB+Insider+Transactions
